Collectively, these data suggest that the role of IGF-1 signaling in rats on metabolic health and AD can be somewhat divergent from lessons in mouse models, and emphasize the importance of complementary species, such as the rat, in refining translational insights from preclinical models. Here, IGF1 is linked to Alzheimer disease.